![]() |
市場調查報告書
商品編碼
1960014
眼科縫線市場-全球產業規模、佔有率、趨勢、機會、預測:按類型、應用、最終用戶、地區和競爭格局分類,2021-2031年Ophthalmic Sutures Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application, By End User, By Region & Competition, 2021-2031F |
||||||
全球眼科縫合線市場預計將從 2025 年的 6.2886 億美元成長到 2031 年的 9.1501 億美元,複合年成長率為 6.45%。
這些特製的超細外科縫線對於在涉及眼球及其周圍結構的眼部手術中精準進入眼部組織至關重要。市場成長的主要驅動力是全球人口老化加劇,這與青光眼和角膜疾病等需要手術介入的老齡化相關疾病發生率上升密切相關。此外,糖尿病視網膜病變和眼外傷的日益普遍也使得這些特殊傷口縫合裝置的需求持續旺盛,以確保患者在術後獲得最佳恢復。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 6.2886億美元 |
| 市場規模:2031年 | 9.1501億美元 |
| 複合年成長率:2026-2031年 | 6.45% |
| 成長最快的細分市場 | 合成 |
| 最大的市場 | 北美洲 |
市場擴張的一大障礙是無縫合技術的日益普及,例如自閉合切口和生物相容性黏合劑,這些技術正在減少對傳統縫合方法的依賴。儘管技術發生了這種轉變,但需要治療的患者數量龐大,這保證了一定的需求水準。根據國際防盲協會(IAPB)2024年的報告,全球約有11億人患有視力障礙,凸顯了對有效眼科手術介入的巨大且持續的需求。
全球老年人口的快速成長正成為市場擴張的主要催化劑,這與白內障和青光眼等老齡化眼科疾病的激增直接相關。隨著眼部組織老齡化成長而退化,手術干預的需求增加,在自閉合技術不足以應對的複雜手術中,高精度縫合線對於傷口縫合至關重要。這種人口結構的變化推高了醫療耗材的消耗速度,為醫療系統處理等待手術的患者帶來了沉重負擔。根據英國皇家眼科醫師學會2024年5月發布的關於選擇性手術目標的報告,英國約有60萬名患者正在等待首次眼科醫生預約,這凸顯了大量手術候選者湧入醫療系統。
同時,角膜移植手術數量的增加推動了專用眼科縫線的消耗,尤其是那些需要特定縫合方式以固定供體角膜片和矯正散光的縫線。與可採用無縫線切口的標準白內障手術不同,角膜移植需要使用細單絲縫線來確保移植片的穩定性並獲得良好的屈光效果。根據美國眼庫協會2024年3月的統計報告,2023年美國共進行了50,925例角膜移植手術,顯示重建手術呈現持續上升趨勢。支持這些治療的商業性規模體現在主要行業參與者的財務表現。例如,愛爾康公司報告稱,2023年全年手術產品淨銷售額達53億美元,顯示眼科手術生態系統具有顯著的經濟影響力。
無縫線手術技術的日益普及對眼科縫合線市場的商業性成長構成了重大阻礙因素。在現代臨床實踐中,尤其是在白內障和屈光矯正手術,微創手術的趨勢正在加速發展,自閉合切口和生物相容性黏合劑有效地取代了傳統的針線縫合。這種轉變是由臨床需求驅動的,例如最大限度地減少術後散光、減輕發炎和加速患者康復。隨著醫療專業人員優先採用這些先進技術來提高手術效率和患者舒適度,標準眼科手術所需的縫合線日常使用量正呈現顯著下降趨勢。
這種技術變革的影響在以往依賴縫合的高頻手術中最為顯著,如今這些手術大多採用極少甚至無需縫合。大量手術轉向這些替代縫合方法,大大縮小了傳統縫合產品的市場。根據美國眼科學會 (AAO) 2024 年的數據,美國每年約進行 400 萬例白內障手術。在如此龐大數量的手術中,無縫線超音波超音波術 (Phacoemulsification) 已成為主流方法,這清楚地表明,現代技術的進步正在直接限制對傳統傷口縫合裝置的需求。
縫合針設計和金屬加工技術的進步正在重塑市場格局。製造商們正在研發超細縫合針,以在精細的眼科顯微手術中保持其結構完整性。這一趨勢滿足了臨床需求,即在穿刺鈣化和纖維化組織時,既要最大限度地減少對角膜和鞏膜層的損傷,又要確保縫合針具有足夠的抗彎曲性。創新製造商正利用先進的熱處理技術和不銹鋼合金,生產具有卓越延展性和鋒利度保持性的針尖,這對於青光眼和視網膜手術中的高精度操作至關重要。例如,2024年10月,Corza Medical推出了其「Onatec」產品線,該產品線採用高度熱處理的不銹鋼,實現了卓越的抗彎曲性和針尖精度,適用於顯微外科手術。
同時,在眼部整形外科領域,無結縫合和特殊縫合技術的應用日益普及,這主要得益於眼周手術對更佳美學效果的需求。外科醫生正逐步採用先進的縫合系統,消除可見的結節。這種縫合系統能夠均勻分散切口處的張力,從而減少疤痕,同時預防肉芽腫的形成和患者的不適。全球眼瞼年輕化手術的激增極大地推動了這項技術的應用,為美容用途的傷口縫合器械創造了巨大的潛在市場。根據國際美容整形外科學會(ISAPS)2024年6月發布的報告,2023年全球眼瞼手術數量將超過170萬例,比上年成長24%,這印證了眼部整形外科領域的快速發展。
The Global Ophthalmic Sutures Market is projected to expand from USD 628.86 Million in 2025 to USD 915.01 Million by 2031, reflecting a compound annual growth rate (CAGR) of 6.45%. These specialized, ultra-fine surgical threads are essential for approximating ocular tissues with high precision during surgeries involving the eye and its surrounding structures. Market growth is largely propelled by the expanding global geriatric population, which correlates with a higher incidence of age-related conditions such as glaucoma and corneal disorders that necessitate surgical intervention. Additionally, the increasing prevalence of diabetic retinopathy and ocular trauma maintains a fundamental demand for these specific wound closure devices to ensure optimal postoperative recovery.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 628.86 Million |
| Market Size 2031 | USD 915.01 Million |
| CAGR 2026-2031 | 6.45% |
| Fastest Growing Segment | Synthetic |
| Largest Market | North America |
A major hurdle to market expansion is the growing adoption of sutureless techniques, including self-sealing incisions and biocompatible adhesives, which decrease reliance on traditional closure methods. Despite this technological transition, the massive volume of patients requiring care guarantees a baseline level of demand. As reported by the International Agency for the Prevention of Blindness in 2024, roughly 1.1 billion people worldwide were living with vision loss, underscoring the immense and continuing need for effective ophthalmic surgical interventions.
Market Driver
The rapidly growing global geriatric population acts as a primary catalyst for market expansion, directly linking to a surge in age-related ocular pathologies like cataracts and glaucoma. As ocular tissues degenerate with age, the need for surgical intervention increases, necessitating high-precision sutures for wound closure in complex procedures where self-sealing techniques are inadequate. This demographic shift places significant pressure on healthcare systems to address procedural backlogs, thereby sustaining the consumption rate of medical consumables. According to the Royal College of Ophthalmologists' May 2024 report on elective activity targets, nearly 600,000 patients in England were waiting for an initial ophthalmologist appointment, highlighting the critical volume of surgical candidates entering the care system.
Simultaneously, the increasing volume of corneal transplantation procedures supports the consumption of specialized ophthalmic sutures, particularly due to the reliance on specific suture patterns to secure donor grafts and manage astigmatism. Unlike standard cataract surgeries that may employ sutureless incisions, keratoplasty requires fine monofilament sutures to ensure graft stability and proper refractive outcomes. The Eye Bank Association of America's March 2024 statistical report noted that domestic keratoplasty procedures in the United States rose to 50,925 in 2023, indicating a sustained upward trend in restorative surgeries. The commercial magnitude of the sector supporting these interventions is reflected in the financial results of major industry players; for instance, Alcon reported $5.3 billion in surgical net sales for the full year 2023, demonstrating the substantial economic impact of the ophthalmic surgical ecosystem.
Market Challenge
The rising adoption of sutureless surgical techniques represents a significant restraint on the commercial growth of the ophthalmic sutures market. Modern clinical practices have increasingly shifted toward minimally invasive procedures, especially in cataract and refractive surgeries, where self-sealing incisions and biocompatible glues effectively replace traditional needle-and-thread closures. This transition is driven by the clinical necessity to minimize postoperative astigmatism, reduce inflammation, and accelerate patient rehabilitation. As medical professionals prioritize these advanced methods to improve surgical efficiency and patient comfort, the routine volume of sutures required for standard ocular interventions is experiencing a measurable decline.
The impact of this technological displacement is most severe in high-volume procedures that historically relied on sutures but now largely operate without them. The sheer scale of surgeries migrating to these alternative closure methods significantly reduces the addressable market for conventional threading products. According to the American Academy of Ophthalmology in 2024, surgeons perform approximately 4 million cataract surgeries annually in the United States. The dominance of sutureless phacoemulsification within such a vast number of procedures illustrates how the evolution of modern techniques directly limits the demand for traditional wound closure devices.
Market Trends
Advancements in suture needle geometry and metallurgy are reshaping the market as manufacturers engineer ultra-fine needles capable of maintaining structural integrity during delicate ocular microsurgeries. This trend addresses the clinical need for needles that resist bending when penetrating calcified or fibrotic tissues while minimizing trauma to the corneal or scleral layers. Innovators are increasingly using advanced tempering processes and stainless steel alloys to produce needle tips with superior ductility and sharpness retention, which are essential for high-precision maneuvers in glaucoma and retinal procedures. For example, Corza Medical announced its Onatec portfolio in October 2024, utilizing highly tempered stainless steel to deliver enhanced bending resistance and needle accuracy for microsurgical applications.
concurrently, the oculoplastic segment is seeing a rising adoption of knotless and specialized suture technologies driven by the demand for superior aesthetic outcomes in periorbital surgeries. Surgeons are shifting toward advanced closure systems that eliminate palpable knots, which can cause granulomas or patient discomfort, while ensuring even tension distribution across the incision to reduce scarring. This technological integration is heavily supported by the surging global volume of eyelid rejuvenation procedures, creating a substantial addressable market for cosmetic-focused wound closure devices. According to the International Society of Aesthetic Plastic Surgery's June 2024 report, eyelid surgery recorded over 1.7 million procedures globally in 2023, reflecting a 24% increase from the previous year and underscoring the expanding scale of the oculoplastic sector.
Report Scope
In this report, the Global Ophthalmic Sutures Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Ophthalmic Sutures Market.
Global Ophthalmic Sutures Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: